IVD in Eastern Europe

 
   Single User - $3,500
   Site License (one location, 10 users) - $5,250
   Corporate License - $7,990


Loading...
Published Aug 28, 2018 | 52 Pages | Pub ID: KLI15760380

IVD in Eastern Europe

IVD companies continue to explore opportunities in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. These countries continue to invest in healthcare infrastructure and insurance coverage for a growing more affluent middle class. Eastern European markets are ripe for change. Many countries are engaging in healthcare reform programs to meet the growing demand for innovative products while containing costs in an increasingly burdensome environment. Aging populations will be a major driver for the use of IVD testing in these countries, generating 3% market growth in countries where markets have been relatively stagnant.

Despite the growing opportunity derived from increasing demand, countries in Eastern Europe are often limited by restricted resources, both financial and human. In comparison to many of the developed European countries, Eastern Europe is losing physicians and other health professionals to westward migration, which continues to place a large burden on the population to experience long waits to see professionals, complete diagnostic tests, and schedule surgeries. These will be some of the biggest challenges for IVD manufacturers in Eastern Europe; but early expansion and sifting through the challenges will likely prove to be financially rewarding in the long-term.

This report provides an overview of developments in the in vitro diagnostics industry in Eastern Europe. The countries covered are
  • Bulgaria
  • Croatia
  • Czech Republic
  • Hungary
  • Poland
  • Romania
  • Russia
  • Slovakia
  • Slovenia
  • Ukraine
  • Other Eastern Europe (Albania, Belarus, Bosnia, Estonia, Herzegovina, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Serbia)
The Eastern European market for in vitro diagnostics is provided in U.S. dollars for the years 2017 – 2022.

The report covers six segments of the IVD market in Eastern Europe:
  • Clinical Chemistry
  • Immunoassay
  • Microbiology
  • Point of Care (POC)
  • Histology
  • Other (includes nucleic acid assays, blood bank ABO, sequencing, prenatal tests and other areas not covered specifically in the above segments)
  • Executive Summary
    • Overview
    • Scope and Methodology
    • Size and Growth of the Market
      • Table IVD in Eastern Europe, 2017-2022 CAGR 3.0%
  • Eastern Europe: Regional Overview
    • Population
      • Table Elderly Dependency Ratio in Eastern European and Other Select Countries, 2010 and 2050
      • Table World Population: Eastern Europe Region (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Slovenia, Ukraine, Other Eastern Europe) , 2005-2025 (million persons)
    • Economic Outlook
      • Table GDP: Eastern Europe Region (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Slovenia, Ukraine, Other Eastern Europe) , 2005-2025 (billion US$)
    • Major Diseases Affecting the Eastern European Population
      • Cardiovascular Diseases
        • Table CVD Deaths by Eastern European Country, Male, Female and Total
      • Cancer
        • Table The Most Frequent Cancers by Eastern European Country (%) As Reported by National Cancer Registry Programs, 2015-2017
      • Diabetes
        • Table People Living with Diabetes in Eastern Europe by Country, Estimates 2017 and Projections 2045 (thousands of people)
    • In Vitro Diagnostic Devices Regulation (IVDR)
  • Country Market Analysis
    • Overview
    • Bulgaria
      • Table Bulgaria In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Croatia
      • Table Croatia In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Czech Republic
      • Table Czech Republic In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Hungary
      • Table Hungary In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Poland
      • Table Poland In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Romania
      • Table Romania In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Russia
      • Table Russia In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Slovakia
      • Table Slovakia In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Slovenia
      • Table Slovenia In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
    • Ukraine
      • Table Ukraine In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
      • Market Drivers
      • Market Inhibitors
      • Market Participant Activity
  • Market Summary: Total Eastern Europe Market
    • Summary
      • Table Eastern Europe In Vitro Diagnostic Sales by Market Segment, 2017-2022 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other, Total) ($ millions)
    • Clinical Chemistry Market
    • Immunoassay Market
    • Microbiology Market
    • Point-of-Care Market
    • Histology Market
    • Other Markets
    • Country Snapshot
      • Table Eastern Europe In Vitro Diagnostic Sales by Country, 2017-2022 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Slovenia, Ukraine, Other Eastern Europe, Total)
      • Table Eastern Europe In Vitro Diagnostic Sales by Country, 2017-2022 - Ten Countries Generate nearly 90% Market Value (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, Slovenia, Ukraine, Other Eastern Europe)
    • ''Other Countries' Snapshot
      • Table 'Other' Eastern Europe In Vitro Diagnostic Sales by Country, 2017-2022 ($ millions) (Albania, Belarus, Bosnia/Herzegovina, Estonia, Kosovo, Latvia, Lithuania, Macedonia, Moldova, Montenegro, Serbia, Total)

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.